# FDA Inspection 1283510 - Lundbeck Seattle BioPharmaceuticals, Inc. - September 12, 2025

Source: https://www.keypedia.com/records/fda_inspections/lundbeck-seattle-biopharmaceuticals-inc/12baee18-1e04-4908-8f89-4012f552c525
Source feed: FDA_Inspections

> FDA Inspection 1283510 for Lundbeck Seattle BioPharmaceuticals, Inc. on September 12, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1283510
- Company Name: Lundbeck Seattle BioPharmaceuticals, Inc.
- Inspection Date: 2025-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1283510 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/lundbeck-seattle-biopharmaceuticals-inc/7af3905c-2fed-42a1-97a8-393c47e84be4)

Company: https://www.keypedia.com/companies/lundbeck-seattle-biopharmaceuticals-inc/322b28d1-cf20-42f2-a384-93c08daee6ae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c